AKT1 and meningioma: Since the majority of TRAF7 tumors harbor a gain-of-function mutation in a single amino acid position in either AKT1 or KLF4, AKT1E17K and KLF4K409Q appear to be the driving force behind TRAF7 meningioma growth.